Amcor
AMCR · NYSEMiscellaneous Manufacturing Industries · Fiscal year ends Dec 31
Amcor reported revenue of $23.5B in the fiscal year ended Jun 2026, up 56.6% from the year before. Operating income was $1.9B, an operating margin of 8.1%, and net income was $1.1B. Operating cash flow of $2.2B less capital expenditure of $922M left free cash flow of $1.2B. Net debt was $12.9B.
Last 5 fiscal years
Revenue and net income
Income statement
| Fiscal year | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 | Jun 2026 |
|---|---|---|---|---|---|
| Revenue | $14.5B | $14.7B | $13.6B | $15B | $23.5B |
| Cost of revenue | $11.7B | $12B | $10.9B | $12.2B | $18.8B |
| Gross profit | $2.8B | $2.7B | $2.7B | $2.8B | $4.7B |
| Research & development | $96M | $101M | $106M | $120M | $170M |
| Selling, general & admin | $1.3B | $1.1B | $1.1B | $1.2B | $1.9B |
| Operating income | $1.2B | $1.5B | $1.2B | $1B | $1.9B |
| Interest expense | $159M | $290M | $348M | $396M | $676M |
| Pre-tax income | $1.1B | $1.3B | $907M | $650M | $1.3B |
| Income tax | $300M | $193M | $163M | $135M | $181M |
| Net income | $805M | $1B | $730M | $511M | $1.1B |
| Diluted EPS | 0.53 | 0.70 | 2.52 | 1.60 | 2.38 |
| Diluted shares | 1,516M | 1,476M | 288M | 319M | 464M |
Balance sheet
| Fiscal year | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 | Jun 2026 |
|---|---|---|---|---|---|
| Cash & equivalents | $775M | $689M | $588M | $827M | $1.1B |
| Receivables | $1.9B | $1.9B | $1.8B | $3.4B | $3.6B |
| Inventory | $2.4B | – | – | – | – |
| Current assets | $5.9B | $5.3B | $5B | $8.4B | $9.3B |
| Net PP&E | $3.6B | – | – | – | – |
| Goodwill | $5.3B | $5.4B | $5.3B | $11.3B | $12.1B |
| Total assets | $17.4B | $17B | $16.5B | $37.1B | $37.1B |
| Payables | $3.1B | $2.7B | $2.6B | $3.5B | $4B |
| Current liabilities | $5.1B | $4.5B | $4.3B | $7B | $7.4B |
| Short-term debt | $14M | $13M | $12M | $141M | $135M |
| Long-term debt | $6.3B | $6.7B | $6.6B | $13.8B | $13.9B |
| Total liabilities | $13.3B | $12.9B | $12.6B | $25.3B | $25.3B |
| Shareholders' equity | $4.1B | $4B | $3.9B | $11.7B | $11.8B |
Cash flow
| Fiscal year | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 | Jun 2026 |
|---|---|---|---|---|---|
| Operating cash flow | $1.5B | $1.3B | $1.3B | $1.4B | $2.2B |
| Capital expenditure | $527M | $526M | $492M | $580M | $922M |
| Free cash flow | $999M | $735M | $829M | $810M | $1.2B |
| Depreciation & amortisation | $625M | $586M | $595M | $722M | $1.5B |
| Stock-based compensation | $63M | $54M | $32M | $74M | $83M |
| Acquisitions | $0 | $121M | $20M | $1.7B | $17M |
| Share buybacks | $601M | $432M | $30M | $0 | $1M |
| Dividends paid | $732M | $723M | $722M | $845M | $1.2B |
| Dividend per share | 0.48 | 0.49 | 2.49 | 2.54 | 2.59 |
Key ratios
| Fiscal year | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 | Jun 2026 |
|---|---|---|---|---|---|
| Revenue growth (YoY) | – | 1.0% | −7.2% | 10.0% | 56.6% |
| Operating income growth (YoY) | – | 21.7% | −19.5% | −16.9% | 88.2% |
| EPS growth (YoY) | – | 33.3% | 257.4% | −36.5% | 48.7% |
| Gross margin | 19.4% | 18.5% | 19.9% | 18.9% | 20.0% |
| Operating margin | 8.5% | 10.3% | 8.9% | 6.7% | 8.1% |
| Net margin | 5.5% | 7.1% | 5.4% | 3.4% | 4.7% |
| Return on equityBlank when equity is negative | 19.7% | 26.0% | 18.8% | 4.4% | 9.4% |
| ROCEEBIT ÷ (assets − current liabilities) | 10.1% | 12.0% | 9.9% | 3.4% | 6.4% |
| Free cash flow margin | 6.9% | 5.0% | 6.1% | 5.4% | 5.2% |
| Cash conversion (CFO ÷ net income) | 1.90x | 1.20x | 1.81x | 2.72x | 1.94x |
| Receivable days | 49 | 47 | 49 | 83 | 57 |
| Inventory days | 76 | – | – | – | – |
| Payable days | 96 | 82 | 86 | 105 | 78 |
| Interest cover | 7.79x | 5.20x | 3.49x | 2.55x | 2.81x |
| Debt ÷ equity | 1.56x | 1.66x | 1.70x | 1.19x | 1.19x |
| Net debtDebt − cash & equivalents; excludes investments; negative = net cash | $5.6B | $6B | $6B | $13.2B | $12.9B |
| Current ratio | 1.15x | 1.19x | 1.17x | 1.21x | 1.25x |
Recent filings
Standardised figures from the company's XBRL filings with the SEC (10-K, 10-Q). Line items follow US GAAP tags, so a company's own statement layout may differ and some lines show “–” where the company does not report that item. Ratios are calculated from these figures. For education only; not investment advice or a recommendation.